PYX Resources: Achieving volume and diversification milestones. Watch the video here.
Just caught up with today’s posts, It’s made a refreshing change to follow a mainly intelligent conversation debated by mature adults for once this evening, much better than the ‘one line day trader’ rubbish that clogs up this and most other boards during trading hours.
At the risk of repeating myself, I’m of the humble opinion that the best moral and financial route to take would be for Novacyt to issue licences to the top ten major pharmas in the world, Pfizer, Roche, Novartis, Merck, GlaxoSmithKline, Johnson & Johnson, AbbVie, Sanofi, Bristol-Myers Squibb and AstraZeneca, allowing them to produce under patent their no.1 assay ‘Primerdesign‘ test.
This would provide the quickest pathway to satisfy the world-wide clamour for the most reliable test available on the market. Having one standardised internationally recognised test would save many more lives and provide vital data to healthcare professionals around the world to accurately track the spread/ containment of the virus.
How much would such a licence cost? Several posters this week have used the word ‘exponential’ in regard to the future share price. The dictionary definition is ‘of an increase, becoming more and more rapid’. I wouldn’t argue with that, but in such a unique and terrifying situation it’s just not possible to predict with any accuracy.
During last few days we have seen on this board share price forecasts ranging anywhere from £5 - £32. Don’t forget to factor in the shananigans of the mms when using your counting beads. Even if this excellent minnow of a company lifted itself onto the FTSE 250 these people would still play games with the daily share price.
Believe it or not, but I’m no longer focusing on the share price, that will take care of itself over the coming months. I just want to see world leaders form a cohesive plan that will contain and eventually eradicate this plague and it’s obvious to any individual with average intelligence that the way forward is to provide the world with as many reliable test kits as soon as possible.
We’ve seen how the developed world has failed miserably to cope with this pandemic, I dread to think of the scenes we will have to endure on our screens when CV-19 takes hold in the third world.
PS – Most of this post also applies to the SNG board, here’s hoping that their trial is also successful, then the NHS can begin to get on top of this terrible virus.
ATVB.
I would advise all investors to use the link below for real news, kindly provided by another poster last week.
https://www.uhs.nhs.uk/ClinicalResearchinSouthampton/Research/News-and-updates/News-and-updates.aspx
All the best to all GENUINE holders.
You are a busy poster Pilgrim - whatever board I look into you've already been there! The main problem I'm having over this weekend is working out how to allocate my investments between SNG and NCYT percentage wise - which will rise the highest and when?
Also there is FARN to consider, who seem to be currently well behind SNG's curve, but have just advertised for a clinical supply chain manager - any mileage in that one do you think?
ATB
Van - I was in sxx back in 2013, even went up onto the site and spoke to the initial core drillers in 2012, as I like to 'do my own research' as they say, Fred came in some years later. Didn't lose my shirt, but it was a harsh lesson.
I have a feeling we'll regain our losses here and with NCYT.
Interesting, but worrying times.
ATVB.
Afternoon Van - Yes, I should have been more specific, I was referring to the number of times you post in general on LSE. Averaging 23 per day on NCYT I see, you have to admit that's either dedication/ ramping/ insider.
I'll give you the benefit of the doubt and go with the former. I think both of these shares are intrinsically linked, both are ethical investments that are ready to take off, which is why many of us are invested in both.
ATVB
Pilgrim - Thanks for the nod on your 06.52 this morning. I'm sure you'll agree this is a short term binary bet, but with unknown upside. I guess the increase in posters will go up in line with the price over the next week. Just as well we can spend time on the screen today, as you just can't take your eyes off this one at the moment.
ATVB
Bella6542 - The £3 mill in appendix 2? - Tricky to call that one, probably wrong to speculate at this delicate stage, things are moving so quickly I doubt we'll have long to wait.
Shares_To Buy - I wouldn't argue with your broad assessment between £5 - £10, this situation is so unique it's impossible to put a figure on it. As an individual, what would you pay if you were struggling for breath and someone said they could help you breathe normally again?
ShareSting - Thanks for the tickup, I don't think they would put anything out there relating to the actual manufacturing process just yet. You're not wrong with your MCAP assessment if this pans out the way we humble investors want. It's also a bonus to be involved in an ethical company with a sound future.
ATVB
Van - Sorry for the late Reply - Myo is short for Myosotis, who was a prolific poster (20,000+) on the sxx site. I was of the opinion he was planted on there by the company. Your sheer number of posts on here makes me wary - once bitten etc, but that's the nature of these boards I guess.
It is looking increasingly likely that the trials for this drug are going to be successful enough to commence world-wide production. SNG have cleverly shown their hand this week, making it clear that they wish to keep their independence by quickly raising more capital, allowing them to carry on their fine work in researching and developing a range of respiratory drugs for differing conditions.
The directors are obviously fully aware that no single company, especially an Aim listed company, has the capacity to supply the world with one product, so it would be morally and financially wrong to hold this back from the big pharma companies.
So how can SNG maximise profit and maintain their independence?
How about selling licences to the major pharmas to produce under patent on an annual basis?
The top ten by revenue are: Pfizer, Roche, Novartis, Merck, GlaxoSmithKline, Johnson & Johnson, AbbVie, Sanofi,
Bristol-Myers Squibb and AstraZeneca.
Imagine reading the RNS detailing the company accounts at the end of April 2021. I don’t know how to type a zillion, but I guess that’s the profit margin we’d be looking at in thirteen months time. Anyone care to guess the share price by then? Of course, in the real world a takeover would almost certainly have taken place, so what price would you be happy with when one of the above came knocking?
Sensible answers only this evening please, we’ve had enough punch and Judy on here over the last week.
(For the record, I invested here substantially three weeks ago).
Frenchcafe - May I offer my humble thanks to both you and your wife for your past and present efforts and I sincerely hope both of you come through this ordeal unscathed - My very best wishes to you both.
T
Careful Fred, VanV could be the new Myo.
This is my last post on this board before transferring to the newly created Facebook page. I am grateful to the team for creating the new page and look forward to sharing new ideas over the coming year.
I have lived and breathed this share for almost eight years now and in that time all form of human life has appeared on this board. There have been some excellent posters, far more intelligent than me, who have been willing to put in the time and effort many of us simply couldn’t afford, sharing their insight and wisdom – I am grateful to you all.
On the other side of the coin there have been so many low-life creatures that have slithered on and off here with a hidden agenda or to simply poke fun at distressed investors – One of the few positives of leaving this site is that we won’t have to encounter these vermin any longer.
Then there are the thousands of posters inbetween, of which many have had their life savings taken from their grasp. Their stories of personal loss and grief will stay with me forever and I know I can speak for many of you by wishing them nothing but good fortune in the future.
This investment has affected my health, relationships with family and close friends and has completely changed my attitude to investing in the future, things that I could never see happening when I bought my first tranche of shares.
None of us were wrong in investing here, the fundamentals were and still are 100% sound. $4 billion was a lot to borrow, but should and could have been achieved with the right course of action.
The Sirius board of directors have shown little remorse at out plight and tomorrow are set to share £19 million of shareholder’s money, some with an extra year’s salary, while we wake up to an average 75% loss.
Never forget at the heart of this was a financier:
Who persuaded you to part with your hard earned cash -
Who failed to raise the finance –
Who was allocated free shares and annual bonuses (total salary 2018 – circa £971,000) -
Who asked for discussion boards like this to be closed down –
Who closed down communication with shareholders.
At the final confrontation between the board and shareholders chairman Scrimshaw showed zero compassion by saying, ‘It’s not a great price, but it is the price.’
My final point is that many, many people have paid a far higher price for believing in the words that came out of your mouth and those of fellow board members over the years.
As individual retail shareholders, we now have a massive advantage going forward, as the next share in which we invest won’t involve the board of directors of Sirius Minerals PLC.
To all those who were unfortunate to have been invloved with this sorry saga, I wish you nothing but the best in the future and look forward to swapping ideas on the newly created Facebook page.
T
Neal - All the very best to you going forward, your efforts with the 'vote no' campaign didn't go unnoticed and nearly paid off.
If the average worker fails in his or her job they get a P45, but the trio of failure: Scrimshaw: Fraser: Staley: take a nice slice of £19 million on Monday when this is formally de-listed. How can this be allowed to happen in a fully developed country and economy?
T
Nice you came back for the very last Friday.
I had to laugh some weeks ago as I overheard this priceless gem while queuing for drinks in a crowded bar on a day trip to Whitby, says it all really:
'It was so cold this morning, I saw Chris Fraser with his hands in his own pockets'.
All the very best to you once again and thanks for all the Friday funnies.
T
'
Re: I actually thought "what would it be like just to walk out to see and just keep going?
My mum actually did just that one cold November evening around midnight some years ago, completely without warning, on South Shore beach at Scarborough. An early morning dog walker found her.
Coming to terms with that took years, but you have to move on with your own life eventually. The two potential suicide posts on here were very hard to read, but such is the nature of this board.
Hope things work out for you Onyx, all the very best.
Hi Fred -I'll definitely be joining later on today. Just read the new group admin rules, that should take out about 95% of posters on here!!
Got a couple of pointers for you before we leave - not advice, just something that may help going forward.
I'll still stay on here until the weekend to see who returns for one last post, be a shame to miss any decent LTholders.
T
Sixthgeneration - If you can get a copy of that e mail, put a screenshot on the sirius minerals investors group facebook page or type the info pls.
T
Just a note to you two guys before you go, your 'vote no' campaign nearly kept us in the game, thanks for all your efforts. I think our views have been aligned for some time, but it wasn't to be. I'm sending a complete file on this to ....(better not say in public).
The injustice of this will take some time to heal, for me it's like turning an oil tanker round to face the opposite direction at the moment, but we have to move on, so all the best to you fellas and best of luck in the future.
T.
Myosotis - 20,000+ postings over nearly a decade - not one single negative word against the BOD - stopped posting as soon as the AA offer came in - invited to join the Sharesoc team - didn't attend the vote meeting last Tuesday, according to the excellent and reliable poster 'Fred', despite being present at most of the AGMs.
Conclusions:
1 He's either too cut-up to publicly discuss recent events.
2 He could be a Sirius man who has been embedded from the start, hiding in plain sight - ala Kim Philby/ Sir Anthony Blunt/ and probably the poster 'Chemistry 2' - Remember him? Also slipped away without saying a word at the same time.
3 Simply can't be bothered wasting his time with unproductive activity.
If it's option 1 he should have the good manners and depth of character to publicly admit he was wrong all along - four days left to do that. If you hear nothing then it could be option 2 or 3.
He more than anyone fuelled the fires of positivity on this board, now we have only dying embers it will be interesting to see what transpires.
T
Since the fateful ‘yes’ vote at last Tuesday’s meeting in London, there have been many comments made on social media sites regarding taking legal action against the board of directors of Sirius Minerals. Some call this a ‘class action’, but this term is only relevant in the USA. In the UK the term is ‘group action or litigation’.
It is with a very heavy heart that I invite you to read and digest the following article, written by corporate lawyer Emma Cameron, who is employed by VWV corporate solicitors in Watford.
The headline reads: ‘Could you be mistaken in thinking that company directors owe fiduciary duties to shareholders?
What Is a Fiduciary Relationship?
A fiduciary relationship arises in circumstances where one party, due to the nature of its position, owes a duty of loyalty, honesty and trustworthiness to another party, usually because it has control over money and or property belonging to that party. The party owing the obligation is known as the "fiduciary", a term originating from the Latin word 'fiducia', meaning 'trust'.
You might then be mistaken for thinking that shareholders, as owners of a company, are owed fiduciary duties by directors, given that directors are entrusted by shareholders to run the day-to-day affairs of a company, and have wide discretion to control and direct its finances and assets. However, as a general rule of English common law, company directors do not, solely by virtue of their office, owe fiduciary duties to shareholders. The High Court revisited this notion whilst presiding over a recent case’…..(continued)
The link below takes you to the full original article.
https://www.vwv.co.uk/news-and-events/blog/business-corporate-law/directors-shareholders-fiduciary-relationship
It’s hard to believe, but company directors are apparently not legally required to display loyalty, honesty and trustworthyness towards individual investors in the UK.
English common law was written by the rich and powerful to ensure they stay rich and powerful. This goes some way to explaining why the top 1% of the population in the UK now own 13% of the total UK wealth* and also why you and I are not going to be allowed to share in the profits that the WoodSmith mine will produce (*office for national statistics).
T